Adherence, Mental Health and Illness Perceptions in Autoimmune Liver Disease: Looking Beyond Liver Function Tests.
Journal
Journal of pediatric gastroenterology and nutrition
ISSN: 1536-4801
Titre abrégé: J Pediatr Gastroenterol Nutr
Pays: United States
ID NLM: 8211545
Informations de publication
Date de publication:
01 09 2021
01 09 2021
Historique:
pubmed:
16
3
2021
medline:
20
12
2022
entrez:
15
3
2021
Statut:
ppublish
Résumé
Autoimmune liver disease is commonly diagnosed during adolescence; a period associated with a higher prevalence of non-adherence, mental health concerns and worse health outcomes. The aim of the study was to explore adherence patterns, mental health and illness perceptions in young people with autoimmune liver disease. Young people with autoimmune liver disease attending a multidisciplinary young adult clinic (16-25 years) completed an electronically administered questionnaire battery. Demographics and disease-related data were collected. Sixty-eight (37 female), median age 17.9 (range 15-22) years completed the screening. Only 51.5% of patients were in remission (aspartate and alanine aminotransferase <36 IU//l) whereas 73% self-reported their adherence >80%. Compared to patients in remission, those not in remission required more immunosuppression, were more depressed and worried but reported a better understanding of their illness. A small but significant correlation was found between aspartate aminotransferase/alanine aminotransferase and adherence percentage (r = -0.27, P < 0.05 and r = -0.29, P < 0.05 respectively). Age was inversely associated with adherence (r = -0.31, P < 0.05), and older patients were more worried (r = 0.44, P < 0.001) and emotionally affected by the condition (r = 0.32, P < 0.01). Adherence behaviours such as forgetting to take medications (63%), taking medications more frequently before attending appointments (44%) and not having a routine for medications (31%) were prevalent, 7% reported intentional non-adherence. Sup-optimal adherence to treatment is common in young people with autoimmune liver disease and associated with mental health problems and certain illness perceptions. Routine exploration of adherence beliefs and barriers to adherence in a non-judgmental, collaborative way is essential to improve outcome in this vulnerable population.
Identifiants
pubmed: 33720085
doi: 10.1097/MPG.0000000000003119
pii: 00005176-202109000-00020
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
376-384Informations de copyright
Copyright © 2021 by European Society for Pediatric Gastroenterology, Hepatology, and Nutrition and North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition.
Déclaration de conflit d'intérêts
The authors report no conflicts of interest.
Références
Ngu JH, Gearry RB, Frampton CM, et al. Predictors of poor outcome in patients with autoimmune hepatitis: a population-based study. Hepatology 2013; 57:2399–2406.
Kirstein MM, Metzler F, Geiger E, et al. Prediction of short- and long-term outcome in patients with autoimmune hepatitis. Hepatology 2015; 62:1524–1535.
Di Giorgio A, Hadzic N, Dhawan A, et al. Seamless management of juvenile autoimmune liver disease: long-term medical and social outcome. J Pediatr 2020; 218:121–129.
Aujoulat I, Deccache A, Charles AS, et al. Non-adherence in adolescent transplant recipients: the role of uncertainty in health care providers. Pediatr Transplant 2011; 15:148–156.
Kerkar N, Annunziato RA, Foley L, et al. Prospective analysis of nonadherence in autoimmune hepatitis: a common problem. J Pediatr Gastroenterol Nutr 2006; 43:629–634.
Sockalingam S, Blank D, Abdelhamid N, et al. Identifying opportunities to improve management of autoimmune hepatitis: evaluation of drug adherence and psychosocial factors. J Hepatol 2012; 57:1299–1304.
Gulati R, Radhakrishnan KR, Hupertz V, et al. Health-related quality of life in children with autoimmune liver disease. J Pediatr Gastroenterol Nutr 2013; 57:444–450.
Schramm C, Wahl I, Weiler-Normann C, et al. Health-related quality of life, depression, and anxiety in patients with autoimmune hepatitis. J Hepatol 2014; 60:618–624.
Hames A, Matcham F, Joshi D, et al. Liver transplantation and adolescence: the role of mental health. Liver Transpl 2016; 22:1544–1553.
Janik MK, Wunsch E, Raszeja-Wyszomirska J, et al. Depression: an overlooked villain in autoimmune hepatitis? Hepatology 2019; 70:2232–2233.
Rayner L, Matcham F, Hutton J, et al. Embedding integrated mental health assessment and management in general hospital settings: feasibility, acceptability and the prevalence of common mental disorder. Gen Hosp Psychiatry 2014; 36:318–324.
Hames AS, A Matcham F, Day J, et al. An integrated model of care for young people with liver disease and transplantation. Eur J Person-Centred Healthcare 2018; 6:
Mieli-Vergani G, Vergani D, Baumann U, et al. Diagnosis and management of pediatric autoimmune liver disease: ESPGHAN Hepatology Committee Position Statement. J Pediatr Gastroenterol Nutr 2018; 66:345–360.
Hames A MJ. Whose problem is it? Improving adherence in young adults. Ethical, Legal and Psychosocial Aspects of Transplantation (ELPAT) . Rotterdam; 2013.
Griva K, Davenport A, Harrison M, et al. Non-adherence to immunosuppressive medications in kidney transplantation: intent vs. forgetfulness and clinical markers of medication intake. Ann Behav Med 2012; 44:85–93.
Shemesh E, Duncan S, Anand R, et al. Trajectory of adherence behavior in pediatric and adolescent liver transplant recipients: the medication adherence in children who had a liver transplant cohort. Liver Transpl 2018; 24:80–88.
Vasylyeva TL, Singh R, Sheehan C, et al. Self-reported adherence to medications in a pediatric renal clinic: psychological aspects. PLoS One 2013; 8:e69060.
Weinman J, Graham S, Canfield M, et al. The Intentional Non-Adherence Scale (INAS): initial development and validation. J Psychosom Res 2018; 115:110–116.
Garfield S, Clifford S, Eliasson L, et al. Suitability of measures of self-reported medication adherence for routine clinical use: a systematic review. BMC Med Res Methodol 2011; 11:149.
Cohen E, Mackenzie RG, Yates GL. HEADSS, a psychosocial risk assessment instrument: implications for designing effective intervention programs for runaway youth. J Adolesc Health 1991; 12:539–544.
Darcy A, Samyn M. Looking after young people with liver conditions: understanding chronic illness management in the context of adolescent development. Clin Liver Dis (Hoboken) 2017; 9:103–106.
Williams R, Alexander G, Aspinall R, et al. New metrics for the Lancet Standing Commission on Liver Disease in the UK. Lancet 2017; 389:2053–2080.